Back to Search
Start Over
All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients
- Source :
- Cancer Research. 66:9299-9307
- Publication Year :
- 2006
- Publisher :
- American Association for Cancer Research (AACR), 2006.
-
Abstract
- Abnormal dendritic cell differentiation and accumulation of immature myeloid suppressor cells (ImC) is one of the major mechanisms of tumor escape. We tested the possibility of pharmacologic regulation of myeloid cell differentiation using all-trans-retinoic acid (ATRA). Eighteen patients with metastatic renal cell carcinoma were treated with ATRA followed by s.c. interleukin 2 (IL-2). Eight healthy individuals comprised a control group. As expected, the cancer patients had substantially elevated levels of ImC. We observed that ATRA dramatically reduced the number of ImC. This effect was observed only in patients with high plasma concentration of ATRA (>150 ng/mL), but not in patients with lower ATRA concentrations (
- Subjects :
- Interleukin 2
Cancer Research
medicine.medical_specialty
Cellular immunity
Myeloid
organic chemicals
Cellular differentiation
Dendritic cell
Dendritic cell differentiation
Biology
Peripheral blood mononuclear cell
biological factors
medicine.anatomical_structure
Endocrinology
Oncology
Myeloid Cell Differentiation
Internal medicine
Cancer research
medicine
neoplasms
medicine.drug
Subjects
Details
- ISSN :
- 15387445 and 00085472
- Volume :
- 66
- Database :
- OpenAIRE
- Journal :
- Cancer Research
- Accession number :
- edsair.doi...........1a82ef364b795ce73e98de00ddcaf14c